R. Lima-Barbosa

Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen

D. Vézina, V. Martel-Laferrière, D. Kaufmann, 2022, Cell reports.

A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile

V. Martel-Laferrière, D. Kaufmann, C. Tremblay, 2022, bioRxiv.

Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity

D. Vézina, D. Kaufmann, E. Bareke, 2023, medRxiv.